 The Companys successful fundraising and inclusion in the Russell MicrocapR Index comes after a series of promising test results for its COVID-19 drug candidates Shelton, Connecticut--Newsfile Corp. - July 23, 2020 - NanoViricides, Inc. NYSE American: NNVC the Company is a development stage, nano-biopharmaceutical Company, with proprietary research focused on countering viral diseases. The Companys lead drug candidate, a topical cream for shingles, has been at the cusp of the IND Investigational New Drug application ... 